Mathieu Laversanne

9PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Time series and spatial modellingMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 10, 2026
Stat Bite: cumulative risk of cancer incidence up to ages 50 and 75 by sex in 2022.

Freddie Bray, Mathieu Laversanne, Salvatore Vaccarella

|Dec 07, 2025
Stat Bite: cumulative risk of cancer incidence and mortality in 2022.

Freddie Bray, Mathieu Laversanne

|Oct 08, 2025
Stat Bite: recent trends in colon cancer incidence at ages 25-49 vs 50-74 in 50 countries.

Freddie Bray, Mathieu Laversanne

|Aug 01, 2025
Stat Bite: National or subnational coverage of population-based cancer registries included in Cancer Incidence in Five Continents, Volume XII.

Freddie Ian Bray, Mathieu Laversanne, Murielle Colombet

|Dec 10, 2024
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045.

Allini Mafra, Mathieu Laversanne, Rafael Marcos-Gragera

Pageof 2